- InvestInvestment SuiteExclusiveFeatures
- PlatformProduct SuiteFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Invest
Platform
Research
Market
Learn
Compare Mutual Funds
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Fund Details
Risk | Very High | - |
Rating | 0.0 | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 1.98 | - |
NAV | ₹1393.68 | - |
Fund Started | 12 Apr 1994 | - |
Fund Size | ₹4180.08 Cr | - |
Exit Load | Exit load of 1%, if redeemed within 90 days. | - |
Risk
Very High
-
Rating
0.0
-
Min SIP Amount
₹100
-
Expense Ratio
1.98
-
NAV
₹1393.68
-
Fund Started
12 Apr 1994
-
Fund Size
₹4180.08 Cr
-
Exit Load
Exit load of 1%, if redeemed within 90 days.
-
Returns
1 Year | 33.85% | - |
3 Year | 12.98% | - |
5 Year | 11.70% | - |
1 Year
33.85%
-
3 Year
12.98%
-
5 Year
11.70%
-
Holding Analysis
Equity | 99.55% | - |
Cash | 0.45% | - |
Equity
99.55%
-
Cash
0.45%
-
Top Holdings
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Maruti Suzuki India Ltd. | 5.46% |
Bayer CropScience Ltd. | 4.31% |
ICRA Ltd. | 3.83% |
Cummins India Ltd. | 3.76% |
Fortis Healthcare Ltd. | 3.66% |
Hindustan Unilever Ltd. | 3.51% |
Honeywell Automation India Ltd. | 3.38% |
Schaeffler India Ltd. | 3.35% |
United Breweries Ltd. | 3.17% |
Glaxosmithkline Pharmaceuticals Ltd. | 3.15% |
-
Fund Manager
Name | Dhaval Joshi | - |
Start Date | 21 Nov 2022 | - |
Name
Dhaval Joshi
-
Start Date
21 Nov 2022
-
About Fund
Description | The scheme would invest exclusively in securities of multinational companies in order to achieve long term growth of capital at relatively moderate levels of risk. A portion of the fund will also be invested in IPO and other primary market offerings. | - |
Launch Date | 12 Apr 1994 | - |
Description
The scheme would invest exclusively in securities of multinational companies in order to achieve long term growth of capital at relatively moderate levels of risk. A portion of the fund will also be invested in IPO and other primary market offerings.
-
Launch Date
12 Apr 1994
-
